- Filed
- Aug 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 8, 2025 | 50.07M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 50.26M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 50.1M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 49.35M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 49.18M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $4.26M |
| Capex | Q2 2025 · Jun 30, 2025 | $7.52M |
| Capex | Q2 2025 · Jun 30, 2024 | $7.8M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$11.69M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | −$11.29M |
| Short Term Investments | Q2 2025 · Jun 30, 2025 | $182.56M |
| Short Term Investments | Q2 2025 · Dec 31, 2024 | $216.46M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $243.42M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $34.14M |
| Cash And Equivalents restated | Q2 2025 · Jun 30, 2024 | $34.18M |
| Cash And Equivalents restated | Q2 2025 · Dec 31, 2023 | $35.19M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $515.39M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $398.81M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $401.9M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $400.1M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $472.19M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $489.02M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $30.15M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $64.56M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $258.54M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $301.6M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $489.49M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $341.57M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $773.93M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $703.49M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $2.05 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $1.78 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$1.62 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$2.05 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $2.05 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $1.78 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$1.62 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$2.05 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $26.91M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $48.81M |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $27.24M |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $55.06M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $4.12M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $8.05M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $4.65M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $9.4M |
| Net Income | Q2 2025 · Jun 30, 2025 | $105.18M |
| Net Income | Q2 2025 · Jun 30, 2025 | $93.2M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$77.99M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$96.88M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$9.65M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$16.84M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | −$78.03M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | −$95.54M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $21.38M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $40.02M |
| Gross Profit restated | Q2 2025 · Jun 30, 2024 | $17.66M |
| Gross Profit restated | Q2 2025 · Jun 30, 2024 | $32.73M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $24.08M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $46.48M |
| Cost Of Revenue restated | Q2 2025 · Jun 30, 2024 | $22.05M |
| Cost Of Revenue restated | Q2 2025 · Jun 30, 2024 | $44.27M |
| Revenue | Q2 2025 · Jun 30, 2025 | $45.45M |
| Revenue | Q2 2025 · Jun 30, 2025 | $86.49M |
| Revenue | Q2 2025 · Jun 30, 2024 | $39.71M |
| Revenue | Q2 2025 · Jun 30, 2024 | $77M |